SMALL CAP MOVERS: ImmuPharma lifted by groundbreaking research
A tough period for AIM showed little sign of letting up as its first constituent of the new year, in the form of Alliance Pharma, this week laid out plans to head for the exit door. Alliance on Friday said it had reached a near-£350 million agreement with largest shareholder DBAY Advisors to be taken … Read more